Aug 2026· Colorectal Disease· Vol 28· 0 citations· 20 references
Medicine
TL;DR
Investigation of the impact of TTRT on overall survival (OS) and anal cancer‐specific survival (ACSS) in a nationwide population‐based cohort from the Swedish Anal Cancer Registry finds no change in survival.
Abstract
A prolonged time from diagnosis to start of radiotherapy (TTRT) for malignant disease may negatively influence survival, but studies in squamous cell carcinoma of the anus (SCCA) are largely lacking. The purpose of this study was to investigate the impact of TTRT on overall survival (OS) and anal cancer‐specific survival (ACSS) in a nationwide population‐based cohort from the Swedish Anal Cancer Registry.
This study aimed to estimate survival and investigate factors associated with PCa‐specific mortality among men treated within the oncology care network of a Brazilian state.
Wesley Rocha Grippa, L. S. Dell'Antonio, C. Dell'Antônio et al.· Cancer Reports· 0 citations
Outcomes for patients with breast cancer have improved over time due to increased screening and the availability of more effective therapies. It is important to recognize that breast cancer is a heterogeneous disease that requires treatment based on molecular characteristics. Early endpoints such as pathologic complete...
A. Abbasi, Vincent Wu, J. Lang et al.· Hematology/Oncology Clinics...· 0 citations
Lung cancer remains the leading cause of cancer‐related mortality worldwide. Despite advances in treatment, postoperative recurrence rates in early‐stage and locally advanced non‐small cell lung cancer (NSCLC) remain substantial. Prognostic models may support risk stratification and guide posttreatment management.
E. Samuel, S. Tissera, E. Paul et al.· Journal of Oncology Research...· 0 citations
Metastasis-free survival (MFS) may not have the same meaning after radical prostatectomy (RP) and radiotherapy (RT), largely because RT is typically combined with prolonged androgen-deprivation therapy (ADT), which can delay the clinical emergence of metastases. Therefore, MFS benefits cannot be assumed to have the sam...
M. Baboudjian, Alessandro Uleri, G. Fallara et al.· European Urology Oncology· 0 citations
This study investigated the impact of advanced molecular imaging, race, socioeconomic status, and metabolic dysregulation on the outcome of salvage radiotherapy (sRT) for prostate cancer recurrence in a clinical trial setting.
I. Lawal, A. Jani, Subir Goyal et al.· Cancer· 0 citations
To evaluate and compare the prognostic value of the 8th and 9th editions of the American Joint Committee on Cancer (AJCC)/Union for International Cancer Control (UICC) staging system in patients with non‐metastatic nasopharyngeal carcinoma (NPC).
Yong-Quan Wei, Dan-Xue Qin, Bao-Qing Yang et al.· Cancer Medicine· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
